This is specifically proposed by the amyloid hypothesis and suggests that tau is a more proximal effector of toxicity than Aβ, which would be in keeping with the observation that tau pathology correlates better with cognitive status than amyloid pathology in AD patients [60]. The gene discussed is MAPT; the disease is Alzheimer disease.